Mechanism | Location in the body or transmission route | Transmission probability |
---|---|---|
ACE2 and TMPRSS2 protease | Heart, kidneys, tests, lungs, nasopharynx, smooth muscle cells, placenta | The risk of transmission is the highest during early pregnancy and decreases toward delivery |
Perinatal transmission | Healthcare services and procedures | Extremely low risk of viral transmission |
Breastfeeding | Breast milk | Extremely low risk of viral transmission |
Sexual intercourse | Semen | Very low risk of viral transmission |
NRP-1 | Hofbauer cells, endothelial cells, smooth muscle cells, adipocytes, Sertoli cells, placenta | This is the most likely route of SARS-CoV-2 transmission |
Macrophages and monocytes | Various tissues – especially placental macrophages | Very high risk of viral transmission |
Level of changes | Pathology | Clinical manifestation |
---|---|---|
Placental |
Venous thrombosis Hemodynamic changes Hypercoagulability Chronic histiocytic intervillositis Syncytiotrophoblast necrosis Fetal and maternal VM Massive perivillous fibrin deposition Lymphoplasmacytic deciduous Extravasation of erythrocytes Thrombosis of placental vessels Cholangitis |
Miscarriage Stillbirth Fetal growth restriction Early preeclampsia Neurosensory development delay CNS disorders FIRS |
Systemic |
Cytokine storm Venous thrombosis Hemodynamic changes Hypercoagulability |